Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer (CCC-Cancer)
Evaluating the Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer
The goal of this clinical trial is to evaluate the communication and care coordinator (CCC) model in a national cancer institute and assess the utility of the model in facilitating serious illness communication (SIC) and care for patients with cancer.
The study aims are:
- To assess the effectiveness of the CCC model in improving patient outcomes.
- To assess the effectiveness of the CCC model in increasing rates of SIC and advance care planning (ACP) record documentation.
- To assess the acceptability of the CCC model to patients and clinicians.
- To evaluate the feasibility of implementing a CCC model in oncology care.
Researchers will compare results from the CCC intervention arm and usual care arm, to see if the CCC model can help improve patient outcomes and facilitate SIC between patients and clinicians.
Patient participants will:
- Follow the assignment of their clinician, who will be assigned randomly to either the usual care group or the intervention group.
- Be assigned a CCC and receive 6 CCC sessions over the course of 3 months (if assigned to CCC intervention arm).
- Complete 3 study assessment visits at baseline, Week 6, and 3 months
- Be invited to a one-time interview to share their study experience (optional, if selected and if in CCC intervention arm).
研究概览
详细说明
Timely SIC may facilitate earlier preferred plan of care documentation and improve patients' sense of peacefulness, hopefulness, and connectedness with their clinicians. The primary goal of the study is to evaluate the CCC model in a national cancer institute and assess the utility of the model in facilitating SIC and care for patients with cancer through a stepped wedge cluster randomized trial. This approach delivers crucial, empirical insights into how SIC can be efficiently and effectively delivered and potentially allow larger scale implementation and dissemination of the CCC model in Singapore, as an effective model for delivering patient support and facilitating patient-clinician communication in patients with advanced cancer.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Shirlyn NEO Hui Shan, MD, PhD
- 电话号码:63065838
- 邮箱:shirlyn.neo.h.s@singhealth.com.sg
研究联系人备份
- 姓名:Benton PT TAM, MSc
学习地点
-
-
-
Singapore、新加坡、168583
- 招聘中
- National Cancer Center, Singapore
-
接触:
- Shirlyn NEO Hui Shan, MD, PhD
-
接触:
- 电话号码:63065838
- 邮箱:shirlyn.neo.h.s@singhealth.com.sg
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
Patient Participants
- Aged 21 and above
- Diagnosed with (a) advanced cancer (stage 3 or 4) or (b) non-advanced cancer, but at high risk of recurrence
- Able to speak English or Chinese, irrespective of race
Clinicians
- Oncologists who are at least of designation of associate consultant and above in NCCS
Exclusion Criteria:
Patient Participants
- Disoriented and thus not able to sign informed consent
- Diagnosed with untreated hearing or visual loss or psychiatric illness
- Active suicidal ideation
Clinicians
- Overseas/not practising in Singapore for a significant amount of time
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:CCC Intervention Arm
Each participant will be assigned a CCC and receive 6 CCC sessions over the course of 3 months. |
CCC sessions will be on exploring participant's illness journey thus far, their concerns, values and priorities. |
|
无干预:Usual Care Arm
Each participant will continue to be followed by the oncologist and receive usual care but will not receive CCC intervention. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Communication Quality
大体时间:Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
Feeling Heard and Understood Survey (FHU) is a validated 4-item scale that has been used in palliative care to measure effectiveness of the SIC conversations and the value of the therapeutic relationship between the care team and the patient. The lowest possible score is 0 and the highest possible score is 16, with a higher score indicating that the care team listens well, respects patient's needs, and provides clear communication. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Quality of Life per FACT-G7
大体时间:Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
Functional Assessment of Cancer Therapy-General-7 Item version (FACT-G7) is a 7-item questionnaire designed to quickly and effectively capture the most relevant issues to cancer. FACT-G7 scores could potentially range from 0-28, with a higher score indicating a better quality of life. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Health Utility
大体时间:Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
EuroQOL Group 5-Dimension (EQ-5D-5L) contains a 5-item descriptive system measuring 5 dimensions: mobility, self-care, usual activities, pain/ discomfort, anxiety/ depression; a visual analogue scale (VAS) measuring overall health status. EQ-5D Index Value (Utility Score) ranges from 0 to 1.0 with higher value indicating better health-related quality of life. The VAS ranges from 0 to 100, with higher scores reflecting better self-rated health. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Spiritual Well-Being
大体时间:Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being 12 Item Scale (FACIT-Sp-12) is a validated 12-item survey that is commonly used in the palliative care setting. It has 3 subscales (meaning, peace and faith). Scores in each subscale can potentially range from 0-16 and the total scores can range from 0-48. A higher score indicates greater spiritual well-being, better ability to find purpose in life and drawing comfort from spiritual resources. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Healthcare Utilization - Rate of Unplanned Acute Hospital Utilization
大体时间:From Study Enrolment to 3 months Post Enrolment.
|
The rate of unplanned acute hospital utilization through the emergency department during the study will be collected. |
From Study Enrolment to 3 months Post Enrolment.
|
|
Healthcare utilization - Length of hospital stay
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on the length of stay in hospital (bed days) will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Hospital Bill
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on hospital bill size will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Type of oncological treatment
大体时间:From 3 months prior to study enrolment until 3 months after study enrolment.
|
Data on the type of oncological treatment used will be collected. |
From 3 months prior to study enrolment until 3 months after study enrolment.
|
|
Healthcare utilization - Chemotherapy usage (line)
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on the line of chemotherapy (first, second or third or subsequent (fourth and onwards)) will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Intensive care unit visit
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on the number of intensive care unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Length of intensive care unit visit
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on the length of intensive care unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - High dependency unit visit
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on the number of high dependency unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Length of high dependency unit visit
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on the length of high dependency unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Location of death
大体时间:From Study Enrolment until Date of Death, up to 3 years.
|
Data on the location of death will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Acceptability - Satisfaction
大体时间:3 months Post Enrolment.
|
Client satisfaction survey is a 4-item, 4-point scale survey in which patients provide ratings on their satisfaction with the intervention, and their views on its relevance, timeliness, and impact. It has been validated in research studies in the outpatient setting around mental health support. Score can range from 4-16, with a higher score indicating greater client satisfaction. |
3 months Post Enrolment.
|
|
Feasibility - Approach-to-Enrolment Rates
大体时间:From Commencement of Study Recruitment till the End of Recruitment, up to 24 months.
|
Approach-to-enrolment rates - where feasibility is defined that at least 60% of those patients approached could be enrolled into the study. |
From Commencement of Study Recruitment till the End of Recruitment, up to 24 months.
|
|
Feasibility - Patient Retention Rate
大体时间:Baseline through Study Completion, estimated as up to 3 years.
|
Patient retention rate - where feasibility is defined that at least 80% of enrolled patients will be able to participate in the study for the planned study duration (3 months). |
Baseline through Study Completion, estimated as up to 3 years.
|
|
Effectiveness - SIC and ACP documentation
大体时间:From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
The number of SIC and ACP documentation per clinician per enrolled patient during the study duration will be tracked during the intervention period(s) and during the control period(s). Clinical notes will also be read to evaluate if there was relevant documentation by clinician on SIC related issues. |
From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
|
Effectiveness - Time spent
大体时间:From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
Time spent by CCC in this model and estimated time spent by clinicians on SICs will be collected. |
From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
|
Acceptability - Clinician experience
大体时间:At end of intervention period (28th month).
|
Clinicians will be surveyed using a modified version of the Clinician Experience Survey (CES). The original CES was developed by Ariadne Labs for the purposes of assessing clinicians perceived feasibility and barriers in engaging patients in SIC. The researchers will modify the CES to form a 4-item scale (score range 4-16), with a higher score indicating greater clinicians' satisfaction with the CCC intervention. |
At end of intervention period (28th month).
|
合作者和调查者
调查人员
- 学习椅:Shirlyn NEO Hui Shan, MD, PhD、National Cancer Centre, Singapore
出版物和有用的链接
一般刊物
- Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011 Apr 23;6:42. doi: 10.1186/1748-5908-6-42.
- Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
- Sudore RL, Fried TR. Redefining the "planning" in advance care planning: preparing for end-of-life decision making. Ann Intern Med. 2010 Aug 17;153(4):256-61. doi: 10.7326/0003-4819-153-4-201008170-00008.
- Bernacki RE, Block SD; American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014 Dec;174(12):1994-2003. doi: 10.1001/jamainternmed.2014.5271.
- Nikbakhsh N, Moudi S, Abbasian S, Khafri S. Prevalence of depression and anxiety among cancer patients. Caspian J Intern Med. 2014 Summer;5(3):167-70.
- Kumar P, Wixon-Genack J, Kavanagh J, Sanders JJ, Paladino J, O'Connor NR. Serious Illness Conversations With Outpatient Oncology Clinicians: Understanding the Patient Experience. JCO Oncol Pract. 2020 Dec;16(12):e1507-e1515. doi: 10.1200/JOP.19.00765. Epub 2020 Aug 4.
- Geerse OP, Lamas DJ, Sanders JJ, Paladino J, Kavanagh J, Henrich NJ, Berendsen AJ, Hiltermann TJN, Fromme EK, Bernacki RE, Block SD. A Qualitative Study of Serious Illness Conversations in Patients with Advanced Cancer. J Palliat Med. 2019 Jul;22(7):773-781. doi: 10.1089/jpm.2018.0487. Epub 2019 Feb 6.
- Paladino J, Koritsanszky L, Nisotel L, Neville BA, Miller K, Sanders J, Benjamin E, Fromme E, Block S, Bernacki R. Patient and clinician experience of a serious illness conversation guide in oncology: A descriptive analysis. Cancer Med. 2020 Jul;9(13):4550-4560. doi: 10.1002/cam4.3102. Epub 2020 May 4.
- Baxter R, Fromme EK, Sandgren A. Patient Identification for Serious Illness Conversations: A Scoping Review. Int J Environ Res Public Health. 2022 Mar 31;19(7):4162. doi: 10.3390/ijerph19074162.
- Agency for integrated care. Advance care planning. Accessed via: aic.sg/Care-Services/Advance-Care-Planning-ACP. Last accessed on February 6th 2026.
- Epstein AS, Riley M, Nelson JE, Bernal C, Martin S, Xiao H. Goals of care documentation by medical oncologists and oncology patient end-of-life care outcomes. Cancer. 2022 Sep 15;128(18):3400-3407. doi: 10.1002/cncr.34400. Epub 2022 Jul 22.
- Karim S, Levine O, Simon J. The Serious Illness Care Program in Oncology: Evidence, Real-World Implementation and Ongoing Barriers. Curr Oncol. 2022 Mar 2;29(3):1527-1536. doi: 10.3390/curroncol29030128.
- Malhotra C, Chaudhry I. Barriers to advance care planning among patients with advanced serious illnesses: A national survey of health-care professionals in Singapore. Palliat Support Care. 2024 Oct;22(5):978-985. doi: 10.1017/S1478951523000214.
- Ahluwalia SC, Levin JR, Lorenz KA, Gordon HS. Missed opportunities for advance care planning communication during outpatient clinic visits. J Gen Intern Med. 2012 Apr;27(4):445-51. doi: 10.1007/s11606-011-1917-0. Epub 2011 Oct 25.
- Shilling DM, Manz CR, Strand JJ, Patel MI. Let Us Have the Conversation: Serious Illness Communication in Oncology: Definitions, Barriers, and Successful Approaches. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e431352. doi: 10.1200/EDBK_431352.
- Nagelschmidt K, Leppin N, Seifart C, Rief W, von Blanckenburg P. Systematic mixed-method review of barriers to end-of-life communication in the family context. BMJ Support Palliat Care. 2021 Sep;11(3):253-263. doi: 10.1136/bmjspcare-2020-002219. Epub 2020 Aug 27.
- Hanley S, Cotner CE, Fenton A, Wright AA, Manz CR. Barriers to Serious Illness Conversations Among Patients with Advanced Cancer: A Qualitative Study. J Pain Symptom Manage. 2025 Feb;69(2):183-189.e4. doi: 10.1016/j.jpainsymman.2024.10.034. Epub 2024 Nov 7.
- Martina D, Geerse OP, Lin CP, Kristanti MS, Bramer WM, Mori M, Korfage IJ, van der Heide A, Rietjens JA, van der Rijt CC. Asian patients' perspectives on advance care planning: A mixed-method systematic review and conceptual framework. Palliat Med. 2021 Dec;35(10):1776-1792. doi: 10.1177/02692163211042530. Epub 2021 Sep 6.
- Patel MI, Periyakoil VS, Blayney DW, Moore D, Nevedal A, Asch S, Milstein A, Coker TR. Redesigning Cancer Care Delivery: Views From Patients and Caregivers. J Oncol Pract. 2017 Apr;13(4):e291-e302. doi: 10.1200/JOP.2016.017327. Epub 2017 Feb 7.
- Patel MI, Kapphahn K, Dewland M, Aguilar V, Sanchez B, Sisay E, Murillo A, Smith K, Park DJ. Effect of a Community Health Worker Intervention on Acute Care Use, Advance Care Planning, and Patient-Reported Outcomes Among Adults With Advanced Stages of Cancer: A Randomized Clinical Trial. JAMA Oncol. 2022 Aug 1;8(8):1139-1148. doi: 10.1001/jamaoncol.2022.1997.
- Patel MI, Ramirez D, Agajanian R, Agajanian H, Coker T. Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer. JAMA Netw Open. 2020 Mar 2;3(3):e201023. doi: 10.1001/jamanetworkopen.2020.1023.
- Lee ASY, Tang SN, Phua GLG, Yee AC, Neo SH. Adaptation of the Serious Illness Conversation Guide to Singapore's Multicultural Setting for Patients With Heart Failure, Renal Failure, or Cancer. Palliat Med Rep. 2024 Mar 26;5(1):122-126. doi: 10.1089/pmr.2023.0086. eCollection 2024.
- Ramakrishnan C, Lee ASY, Malhotra C, Phua GLG, Yee A, Neo SH. Adaptation of the serious illness conversation guide to a multicultural context in Singapore: a qualitative study. BMJ Open. 2025 Oct 23;15(10):e098264. doi: 10.1136/bmjopen-2024-098264.
- Ng A, Phua GL, Neo HS. Iterative adaptation and acceptability testing of the serious illness conversation guide for use with mandarin-speaking patients. Pal Med Rep. 2025 Nov;11(1):564-573.
- Ng A, Sivasamy V, Neo SHS. Cultural adaptation of the serious illness conversation guide for caregivers of persons with dementia in Singapore. BMC Geriatr. 2025 Dec 30;25(1):1075. doi: 10.1186/s12877-025-06761-4.
- Ng A, Yeo SM, Neo SH. Patient Readiness for Serious Illness Conversations: Identifying Psycho-Emotional Barriers Through a Phenomenological Lens. Psychooncology. 2025 Nov;34(11):e70317. doi: 10.1002/pon.70317.
- Gov.sg. Scribe. Accessed via: https://reports.open.gov.sg/scribe/overview Last accessed on February 9th, 2026.
- Chan HY, Leung DY, Lam PT, Ko PP, Lam RW, Chan KS. Effect of motivational interviewing to promote advance care planning among palliative care patients in ambulatory care setting: a randomized controlled trial. BMC Palliat Care. 2025 Jan 31;24(1):31. doi: 10.1186/s12904-025-01667-9.
- Edelen MO, Rodriguez A, Huang W, Gramling R, Ahluwalia SC. A novel Scale to Assess Palliative Care Patients' Experience of Feeling Heard and Understood. J Pain Symptom Manage. 2022 May;63(5):689-697.e1. doi: 10.1016/j.jpainsymman.2022.01.002. Epub 2022 Jan 10.
- Bandini JI, Schulson LB, Messan Setodji C, Williams J, Ast K, Ahluwalia SC. "Palliative Care Is the Only Medical Field That I Feel Like I'm Treated As a Person, Not As a Black Person": A Mixed-Methods Study of Minoritized Patient Experiences with Palliative Care. J Palliat Med. 2023 Feb;26(2):220-227. doi: 10.1089/jpm.2022.0237. Epub 2022 Aug 16.
- FACIT.org. Functional assessment of cancer therapy-general-7 item version. Accessed via: facit.org/measures/fact-g7. Last accessed on February 8th, 2026.
- EUROQOL. EQ-5D-5L. Accessed via: euroqol.org/information-and-support/euroqol-instruments-eq-5d-5l/. Last accessed on February 8th, 2026.
- FACIT.org. Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being 12 Item Scale (FACIT-Sp-12). Last accessed via: https://www.facit.org/measures/facit-sp-12 Accessed on February 8th, 2026.
- CSQ scales. CSQ-4. Accessed via: https://csqscales.com/product/csq-04/ Last accessed on February 8th, 2026.
- Pedersen H, Skliarova T, Attkisson CC, Lara-Cabrera ML, Havnen A. Measuring patient satisfaction with four items: validity of the client satisfaction questionnaire 4 in an outpatient population. BMC Psychiatry. 2023 Nov 7;23(1):808. doi: 10.1186/s12888-023-05310-w.
- Ariadne Labs. ARIA. Accessed via: https://www.ariadnelabs.org/aria/ Last accessed February 2nd, 2026.
- Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101. doi.org/10.1191/1478088706qp063oa
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.